Book contents
- Rare Causes of Stroke
- Rare Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- 1 Inflammatory Conditions
- 2 Infectious and Postinfectious Vasculitis
- 3 Hypercoagulable Causes of Stroke
- 4 Drug-Related Stroke
- 5 Hereditary and Genetic Causes of Stroke
- Chapter 5.1 Genetic Collagen Disorders
- Chapter 5.2 Genetic Small-Vessel Diseases
- Chapter 5.3 Genetic Metabolic Diseases
- Chapter 5.3 Chapter
- 6 Rare Causes of Cardioembolism
- 7 Vasospastic Conditions and Other Vasculopathies
- 8 Other Non-inflammatory Vasculopathies
- 9 Venous Occlusive Conditions
- 10 Bone Disorders and Stroke
- Index
- References
Chapter 5.3 - Chapter
from 5 - Hereditary and Genetic Causes of Stroke
Published online by Cambridge University Press: 06 October 2022
Edited by
Book contents
- Rare Causes of Stroke
- Rare Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- 1 Inflammatory Conditions
- 2 Infectious and Postinfectious Vasculitis
- 3 Hypercoagulable Causes of Stroke
- 4 Drug-Related Stroke
- 5 Hereditary and Genetic Causes of Stroke
- Chapter 5.1 Genetic Collagen Disorders
- Chapter 5.2 Genetic Small-Vessel Diseases
- Chapter 5.3 Genetic Metabolic Diseases
- Chapter 5.3 Chapter
- 6 Rare Causes of Cardioembolism
- 7 Vasospastic Conditions and Other Vasculopathies
- 8 Other Non-inflammatory Vasculopathies
- 9 Venous Occlusive Conditions
- 10 Bone Disorders and Stroke
- Index
- References
Summary
SLE is an autoimmune chronic progressive disease which affects the central and peripheral nervous system and causes different neuropsychiatric symptoms. Stroke is the most severe complication of SLE and the incidence rate is approximately 3-20% especially in the first five years of the disease. Many factors such as high level of aPL, hyperhomocysteinemia, lupus disease activity, cerebral vasculitis, emboli from Libman-Sacks endocarditis, accelerated atherosclerosis cause stroke in SLE. Immune complex deposition in vascular endothelium, intrathecal immune complexes and other inflammatory mediators are involved in the pathogenesis of vasculopathy and vasculitis. Here, we present a 41-year-old Syrian woman with diagnosis of SLE and antiphospholipid antibody syndrome
- Type
- Chapter
- Information
- Rare Causes of StrokeA Handbook, pp. 253 - 261Publisher: Cambridge University PressPrint publication year: 2022
References
El-Hattab, AW, Adesina, AM, Jones, J, Scaglia, F. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116: 4–12.CrossRefGoogle ScholarPubMed
Finsterer, J, Wakil, SM. Stroke-like episodes, peri-episodic seizures, and MELAS mutations. Eur J Paediatr Neurol. 2016;30: 1–6.Google Scholar
Hirano, M, Ricci, E, Koenigsberger, MR, et al. MELAS: An original case and clinical criteria for diagnosis. Neuromuscul Dis. 1992;2(2): 125–135.CrossRefGoogle ScholarPubMed
Hsu, YHR, Yogasundara, H, Parajuli, N, et al. MELAS Syndrome and cardiomyopathy: Linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev. 2016;21(1): 103–116.CrossRefGoogle ScholarPubMed
Ito, H, Mori, K, Kagami, S. Neuroimaging of stroke-like episodes in MELAS. Brain Dev. 2011;33: 283–288.CrossRefGoogle ScholarPubMed
Koening, MK, Emrick, L, Karaa, A, et al. Recommendations for the management of strokelike episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes. JAMA Neurol. 2016;73(5): 591–594.CrossRefGoogle Scholar
Lee, S, Oh, DA, Bae, EK. Fixation-off sensitivity in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Seizure. 2019;64: 6–7.CrossRefGoogle ScholarPubMed
Rimiano, G, Vollono, C, Dono, F, Servidei, S. Drug-resistant epilepsy in MELAS: Safety and potential efficacy of lacosamide. Epilepsy Res. 2018;139: 135–136.CrossRefGoogle Scholar
Santa, KM. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Pharmacotherapy. 2010;30(11): 1179–1196.Google Scholar
Yatsuga, S, Povalko, N, Nishioka, J, et al. MELAS: A nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820(5): 619–624.CrossRefGoogle Scholar
Hovsepain, DA, Galat, A, Chong, RA, et al. MELAS: Monitoring treatment with magnetic resonance spectroscopy. Acta Neurol Scand. 2019;139(1): 82–85.CrossRefGoogle Scholar
Malhotra, K, Liebeskind, DS. Imaging of MELAS. Curr Pain Headache Rep. 2016;20: 54.CrossRefGoogle ScholarPubMed
Muramatsu, D, Yamaguchi, H, Iwasa, K, Yamada, M. Cerebellar hyperintensity lesions on diffusion-weighted MRI in MELAS. Intern Med. 2019;58(12): 1797–1798.CrossRefGoogle ScholarPubMed
Santamarina, E, Alpuente, A, Maisterra, O, et al. Perampanel: A therapeutic alternative in refractory status epilepticus associated with MELAS syndrome. Epilepsy Behav Case Rep. 2019;11: 92–95.CrossRefGoogle ScholarPubMed